Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00633503 · ClinicalTrials.gov registry record

Monitoring of Tissue Transfer Flaps by Modulated Imaging (MI) Spectroscopy

A clinical trial, sponsored by University of California, Irvine.

Completed
Registry status
26
Enrollment target

NCT00633503: Completed study, sponsored by University of California, Irvine.

NCT00633503 is a clinical trial that has completed, run by University of California, Irvine. The registered enrollment target is 26 participants. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00633503 has completed, sponsored by University of California, Irvine.

COMPLETED
Registry status
26 participants
Enrollment target

Study Summary

Tissue transfer flaps are a method of moving tissue from a donor location to a recipient location. In the case of a free tissue transfer flaps, the blood vessels to the transferred tissues are detached and then re-attached to different arteries \& veins at the recipient site. The process of reconstructive surgery using tissue transfer flaps allows for improved results in terms of functionality, aesthetic appearance, and psychological well-being in patients requiring reconstructive surgery after cancer resection or trauma. The process of reconstructive surgery using tissue transfer flaps is not without complications. These complications may include acute arterial or venous occlusion, as well as the development of late complications such as fat necrosis and flap atrophy. The purpose of this pilot study is to determine if a novel, unique, portable, non-contact optical imaging device developed at the Beckman Laser Institute called Modulated Imaging (MI) can detect changes in a flap's optical properties, which can correlate with arterial or venous occlusion or with the development of fat necrosis or flap atrophy. The study would also evaluate if changes in the tissue transfer flap's optical properties, as detected by the device could be employed as a monitoring device in the post-operative period after reconstructive surgery. The MI device's detection of specific optical properties of a tissue flap could also potentially be used as a diagnostic tool to predict the likelihood of the development of fat necrosis or flap atrophy in a delayed fashion several months after reconstructive surgery. Prior animal and clinical studies using similar devices have demonstrated that changes in the total hemoglobin concentration and percentage of oxygenated hemoglobin in the tissue transfer flap can be used to differentiate between arterial and venous occlusion. These other similar devices have been shown to be able to detect venous occlusion prior to clinical manifestations of venous

Trial Details

FieldValue
Enrollment Target 26 participants
Start Date 2011-01
Est. Completion 2020-01-15
University of California, Irvine

368 total trials

What the finished NCT00633503 record still lists

NCT00633503 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 26 participants, a relatively small participant target.

The record links to 0 conditions, and to 0 interventions.

NCT00633503 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT00633503 about?

NCT00633503 is a clinical study titled "Monitoring of Tissue Transfer Flaps by Modulated Imaging (MI) Spectroscopy". Tissue transfer flaps are a method of moving tissue from a donor location to a recipient location. In the case of a free tissue transfer flaps, the blood vessels to the transferred tissues are detached and then re-attached to different arteries \& veins at the recipient site. The process of reconstr...

What is the current status of trial NCT00633503?

This trial is currently completed. The enrollment target is 26 participants. The study started on 2011-01. Estimated completion is 2020-01-15.

Who is sponsoring clinical trial NCT00633503?

This trial is sponsored by University of California, Irvine, which has 368 total clinical trials registered on ClinicalTrials.gov.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02646475 · 26 participants · Phase 1

    Metabolic Effects of Angiotensin-(1-7)

  • NCT03603223 · 26 participants · Phase 2

    Pembrolizumab in Treating Participants With Leukoplakia

  • NCT04063592 · 26 participants · NA

    AMI Construction in Lower Extremity Residual Limbs

  • NCT04906460 · 26 participants · Phase 1

    Open-label Study of WVE-N531 in Patients With Duchenne Muscular Dystrophy (FORWARD-53)

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT00633503, the US trial registry maintained by the National Library of Medicine. NCT00633503 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.